Boehringer to cap out-of-pocket inhaler cost at $35 per month

Boehringer to cap out-of-pocket inhaler cost at $35 per month

Submitted by admin on March 7, 2024 - 11:08am
Source: 
Reuters
News Tags: 
Boehringer Ingelheim
drug pricing
Atrovent
Combivent Respimat
Spiriva HandiHale
COPD
Headline: 
Boehringer to cap out-of-pocket inhaler cost at $35 per month
snippet: 

Boehringer Ingelheim will cap out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma at $35 per month starting June 1, the German drugmaker said on Thursday.

Do Not Allow Advertisers to Use My Personal information